Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 11, 2025
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
Journal: The New England journal of medicine
Published: March 20, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials.
Journal: Breast cancer research and treatment
Published: January 26, 2024
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 06, 2020
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.
Journal: The Lancet. Haematology
Published: July 25, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026